Apr 7, 2026 · Our Mission GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine …

GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, software, and …

Samsung and GRAIL Announce Strategic Collaboration to Bring GRAIL’s Galleri® Multi-Cancer Early Detection Test to Asia View Press Release

Jun 18, 2025 · Cancer Detection and Positive Predictive Value Substantially Higher Than the Previously Published PATHFINDER Study MENLO PARK, Calif., June 18, 2025 — GRAIL, Inc. (Nasdaq: …

GRAIL uses advanced machine learning algorithms and pattern recognition to “read” methylation patterns. Using these two principles, the Galleri test has three scientific steps: Extract and sequence …

To pursue a mission like GRAIL’s, it takes a unified collective of courageous, adaptable, and open-minded big thinkers dedicated to creating a better world. Because we’ve set our sights high, the work …

Feb 12, 2025 · GRAIL’s targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk …

Oct 16, 2025 · Initially, tests will be performed in GRAIL’s clinical laboratory in Research Triangle Park, North Carolina. “We look forward to partnering with Samsung to bring multi-cancer early detection to …

This is a prospective, multi-center interventional study of the Galleri® multi-cancer early detection test with return of test results for participants enrolled through healthcare systems in North America.

Feb 19, 2026 · The Primary Endpoint of Statistically Significant Combined Stage III-IV Reduction Was Not Met, However A Favorable Trend Was Observed Over Time GRAIL Announces U.S. Sales …